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Abstract
Eukaryotic cells form a variety of adhesive structures to connect with their environment and to regulate cell motility. In
contrast to classical focal adhesions, podosomes, highly dynamic structures of different cell types, are actively engaged in
matrix remodelling and degradation. Podosomes are composed of an actin-rich core region surrounded by a ring-like
structure containing signalling molecules, motor proteins as well as cytoskeleton-associated proteins. Lasp-1 is a
ubiquitously expressed, actin-binding protein that is known to regulate cytoskeleton architecture and cell migration. This
multidomain protein is predominantely present at focal adhesions, however, a second pool of Lasp-1 molecules is also
found at lamellipodia and vesicle-like microdomains in the cytosol. In this report, we show that Lasp-1 is a novel
component and regulator of podosomes. Immunofluorescence studies reveal a localization of Lasp-1 in the podosome ring
structure, where it colocalizes with zyxin and vinculin. Life cell imaging experiments demonstrate that Lasp-1 is recruited in
early steps of podosome assembly. A siRNA-mediated Lasp-1 knockdown in human macrophages affects podosome
dynamics as well as their matrix degradation capacity. In summary, our data indicate that Lasp-1 is a novel component of
podosomes and is involved in the regulation of podosomal function.
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Introduction
Podosomes are highly dynamic adhesion structures that are
constitutively formed in monocytic cells such as macrophages,
dendritic cells, or osteoclasts, [1,2,3]. In addition, endothelial cells,
smooth muscle cells, as well as glomerular podocytes, have been
shown to form podosomes upon stimulation with cytokines,
growth factors or phorbol esters [4,5,6,7,8]. Podosomes play a
role in cell adhesion and matrix degradation, but their precise
function in tissue invasion is still under consideration [9,10]. On
the molecular level, podosomes consist of an actin-rich core and
associated proteins embedded in a ring-like structure of plaque
molecules and signalling proteins.
Recent studies have shown that the formation of podosomes
occurs very rapidly and starts with a clustering of podosome
initiation factors. Subsequently in these cell type a recruitment of
the actin polymerization machinery and a later maturation of
podosomes occur [11,12,13].
A variety of molecules have been detected at podosomes
including focal adhesion proteins (paxillin, vinculin, zyxin), actin
assembly factors (Arp2/3, cortactin, palladin, Wiskott-Aldrich
syndrome proteins ((N-)WASP), GTPases (arf6, cdc42, dynamin 2,
rab5, rab7), transmembrane receptors, signalling molecules (src,
tks5) and various matrix metalloproteinases [1,2,9,10]. Most of
these proteins can be clearly localized to either the podosome core
or the ring structure.
LIM-and-SH3-domain-protein-1 (Lasp-1) is a multidomain
protein that is known to regulate cytoskeleton dynamics [14,15].
An increased level of Lasp-1 protein in carcinoma cells supports
their motility and invasive character, whereas a reduced Lasp-1
expression inhibits chemotactic-induced migration of cultivated
kidney cells [16,17]. Lasp-1 is mainly localized at focal adhesions
and F-actin-rich structures such as stress fibres and lamellipodia
[18]. In addition, Lasp-1 shows a perinuclear accumulation at
highly dynamic, vesicle-like microdomains [17,18,19]. A targeted
disruption of the Lasp-1 gene in Drosophila causes a mislocation of
cells in the testis [20], whereas Lasp-1 knockout mice display a
disturbed gastric secretion [21].
The Lasp-1 protein is composed of an aminoterminal LIM
domain, followed by two F-actin-binding nebulin (NEBU)
domains, a Linker region and a carboxyterminal SH3 domain
[15,22]. The binding to F-actin is mainly mediated by the nebulin
repeats of Lasp-1 [23]. The Lasp-1 SH3 domain interacts with
zyxin, a mechanosensitive regulator of actin assembly, and
controls its recruitment to focal adhesions [24,25]. A second
identified SH3-binding partner of Lasp-1 is palladin, a protein
which is involved in actin assembly, too [8,26].
Lasp-1 displays several phosphorylation motifs for cAMP-
dependent serine/threonine kinases (PKA/PKC) as well as a
substrate-recognizing sequence for the Abelson tyrosine kinase
(Abl) [14,27]. Furthermore, the subcellular distribution and
physiological activity of Lasp-1 is controlled by phosphorylation
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ylation in fibroblasts prevents its localization at focal contacts and
promotes its perinuclear enrichment [17].
The data presented in this study demonstrate that Lasp-1 is a
component of podosomes in primary human macrophages and
activated rat smooth muscle (A7r5) cells. Live cell imaging
analysis, in combination with a siRNA-mediated knockdown
approach demonstrates that Lasp-1 influences several parameters
of podosome dynamics and also regulates podosome function by
influencing their matrix degradation capacity.
Materials and Methods
Antibodies
Monoclonal antibodies directed against green fluorescent
protein (GFP) were purchased from Clontech (Heidelberg,
Germany); against zyxin, gelsolin, and paxillin from BD
Biosciences (Heidelberg, Germany), against vinculin from Synap-
tic Systems (Go ¨ttingen, Germany) and Sigma-Aldrich (Hamburg,
Germany), and against Arp2 from Abcam (Cambridge, UK).
Polyclonal antibodies against Lasp-1 have been described earlier
[28]. Fluorochrome-conjugated secondary antibodies, as well as
phalloidin, coupled to the fluorescent dyes Alexa 488/2594/
2568/2647 were purchased from Molecular Probes (Go ¨ttingen,
Germany) and Invitrogen. Horseradish peroxidase-conjugated
secondary antibodies were purchased from Dianova (Hamburg,
Germany).
Plasmids
The pcDNA3.1-Lasp-1 plasmid was described earlier [27].
Other Lasp-1 constructs, including truncation mutants, were
either subcloned, or produced by PCR and cloning into the
pEGFP-C1 or pDsRed1-N1 vectors (Clontech). The pDsRed2-C1
construct containing mouse cortactin cDNA (kind gift from A.
Mak, Queen’s University, Kingston, Canada) was described
previously [13]. The pmRFP-Actin construct was a kind gift of
M. Ba ¨hler, (University Mu ¨nster, Mu ¨nster, Germany). The EYFP-
vinculin construct was a kind gift from A. Bershadsky (Weizmann
Institute of Science, Rehovot, Israel), as well as MT1-MMP-
mCherry from P. Chavrier (Institut Curie, Paris, France). pLifeact-
TagGFP2 was purchased from ibidi (Martinsried, Germany).
Cell culture, drug treatment and transfection
Human peripheral blood leukocytes were isolated by centrifu-
gation of heparinized blood or buffy coats (kindly provided from F.
Bentzien, University Medical Center Hamburg-Eppendorf, Ger-
many) in Ficoll (Biochrom, Berlin, Germany). Monocytic cells
were isolated with magnetic anti-CD14 antibody beads and MS+
separation columns (Miltenyi Biotec, Auburn, CA), according to
the manufacturer’s instructions and seeded onto glass coverslips at
a density of 5610
4 or 35 mm plastic wells at a density of 1610
6.
Cells were cultured in RPMI containing 20% cell-free autologous
serum at 37uC, 5% CO2 and 90% humidity and differentiated into
macrophages through plate adherence over 6 days. Autologous
cell-free serum, which was isolated from whole blood using Serum
Separation tubes (S-MonovetteH from Sarstedt, Nu ¨mbrecht,
Germany), filtrated through StericupH Filter Units (Millipore)
and used without previous heat inactivation. Medium was changed
every 3–4 days.
A7r5 rat smooth muscle cells (ATCC) were grown on glass
coverslips in high glucose Dulbecco’s Modified Eagle Medium
(DMEM) without phenol red, containing 10% fetal calf serum and
16 penicillin/streptomycin. For the expression of EGFP, mRFP
or DsRed fusion proteins, A7r5 cells were transfected with plasmid
DNA using Fugene HD reagent (Roche, Mannheim, Germany)
following the manufacturer’s instructions. 48 hours after transfec-
tion, podosome formation was induced by PDBu treatment for the
indicated times. Transfection of macrophages was described
previously [29,30].
Lysate preparation
Cells were either lysed directly into Laemmli sodium dodecyl
sulphate (SDS) sample buffer and boiled for 5–10 minutes or
scraped into lysis buffer (LB, 20 mM Tris-HCl (pH 7.5), 25 mM
NaCl, 50 mM NaF, 15 mM Na4P2O7, 1% TritonX-100, 1 mM
EDTA, Complete Protease Inhibitor, Roche, Mannheim, Germany)
and lysed by 10 passes through a 26-gauge needle. Cell lysates
were centrifuged at 14.0006ga t4 uC and supernatants were stored
at 280uC until further use.
Western blotting
Western blotting was performed using standard techniques [31].
Antibodies were diluted in blocking buffer containing 5% skim
milk powder in PBS/Tween. After washing, the membranes were
incubated with respective secondary antibodies coupled to
horseradish peroxidase. Finally, the membranes were washed
and developed using the Lumilight chemiluminiscence detection
kit (Roche) and X-ray film developer.
Lasp-1 siRNA knockdown
Control siRNA duplexes (59-TTCTCCGAACGTGT-
CACGTTT-39, 20 nM, Qiagen, Hilden, Germany) as well as
validated stealth siRNA oligo A (59-AAGGTGAACTGTCTG-
GATAAG-39, 20 nM, Invitrogen) targeting rat Lasp-1 mRNA
were transfected into A7r5 cells with the use of Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s
recommendations. Preparation of A7r5 cell lysates and immuno-
fluorescence microscopy of cells grown on coverslips, respectively,
were carried out 72 h posttransfection to determine the efficiency
of the siRNA-mediated Lasp-1 knockdown.
Podosome formation in A7r5 Lasp-1 knockdown cells was
induced by PDBu treatment (1 mM for 30 min) 72 h posttransfec-
tion. Cells were fixed and stained with phalloidin-Alexa594 to
visualize the actin core of podosomes. The number of podosomes
per cell after siRNA treatment was determined and quantitatively
analyzed using a student t-test. At least 35 cells per coverslip from
three different experiments were counted.
Human macrophages were transfected in two steps (78 h and
96 h in total) with two different siRNA duplexes (Oligo A: -59-
AAGGTGAACTGTCTGGATAAG-39 and Oligo C:-59-
GCATGCTTCCATTGCGAGA-39,1mM each, ThermoScien-
tific (Bonn, Germany)) targeting human Lasp-1 mRNA or control
siRNA targeting firefly luciferase (59-AGGTAGTG-
TAACCGCCTTGTT-39) using a MicroPorator MP-100 (Peq-
Lab, Erlangen, Germany) with the following specifications: pulse
voltage 1000 V, pulse width 40 ms, pulse number 2.
Preparation of lysates from siRNA-transfected cells was carried
out 78 h and 96 h posttransfection to determine the efficiency of
the siRNA-mediated Lasp-1 knockdown using Western blotting
analysis.
Immunofluorescence analysis
A7r5 cells grown on coverslips were fixed in 4% paraformal-
dehyde in PBS. Human macrophages were fixed with 3.7%
formaldehyde in PBS and permeabilized in ice-cold acetone and
0.5% Triton X-100, respectively. Endogenous proteins were
detected by subsequent incubation of the cells with primary and
Lasp-1 Regulates Podosomes
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temperature. After washing, specimen were mounted in Vectastain
mounting medium (Vector Laboratories, Burlingame, CA) or
Mowiol (Calbiochem, Schwalbach, Germany) containing p-
phenylendiamine (Sigma-Aldrich) as anti-fading reagent, and
sealed with nail polish. Samples were analyzed on a Leica
photomicroscope (Leica, Wetzlar, Germany) attached to a Spot 2
Slider digital camera (Meyer Instruments, Houston, TX).
Confocal microscopy was performed on a confocal laser scanning
microscope (Leica) or a LSM510 Meta microscope (Carl Zeiss,
Jena, Germany). Substitution of primary antibodies by non-
immune serum served as negative controls.
For analyzing the number and diameter of podosomes, primary
human macrophages were seeded on glass coverslips in a density
of 1610
5 cells. After 6 h, the cells were fixed, permeabilized and
stained with Alexa 488-coupled phalloidin for highlighting
podosome cores. The numbers of podosomes were evaluated
using ImageJ and GraphPad Prism software. In total, 168 cells
were used from three different donors. For the diameter of the
podosome cores, in total 24 cells from three different donors were
analysed using Volocity 3D Image Analysis Software (PerkinEl-
mer, Rodgau, Germany) and evaluated with Excel and GraphPad
Prism software.
For analysing the number of podosomes contacted by MT1-
MMP containing vesicles, MT1-MMP-mCherry was overex-
pressed for 18 h in primary human macrophages, then fixed,
permeabilized and stained with Alexa 488 coupled phalloidin. The
fluorescence intensity of single podosomes was measured using
ImageJ software and evaluated with Excel and GraphPad Prism
software. In total, 12 cells from three different donors were
analysed.
Live cell imaging
24 h posttransfection, A7r5 cells were seeded onto 35 mm m-
dishes (ibidi, Martinsried, Germany) and intracellular dynamics of
recombinant EGFP-, mRFP- or DsRed-tagged proteins were
analyzed with the live cell imaging system Biostation IM (Nikon,
Duesseldorf, Germany). Therefore, an internal sealed chamber
with humidified 5% CO2 and 37uC was used. Pictures from
selected cells were taken every 30 sec over time periods of 5–
30 min.
Primary human macrophages were seeded onto 12 mm glas
bottom dishes (Willco Wells BV, Amsterdam, Netherlands). The
dynamics of single podosomes or the area of all podosomes, were
analysed 18 h posttransfection of Lifeact-TagGFP2. Pictures from
single cells were taken every 10 sec over time periods of 30 min.
For evaluation, in total eleven cells,from three different donors,
were analysed, using Volocity 3D Image Analysis Software and
GraphPad Prism. Rework of movies was done using After Effects
CS5 (Adobe, Neu-Isenburg, Germany).
Matrix degradation assay
A matrix degradation assay was performed as described earlier
[32]. In brief, gelatin (from swine, Roth, Karlsruhe, Germany) was
fluorescently labeled with NHS-rhodamine (ThermoScientific,
Rockford, IL). Coverslips were coated with labeled matrix
solution, fixed in 0.5% glutaraldehyde and washed with 70%
ethanol and medium. SiRNA-transfected human macrophages
were seeded on coated coverslips with a density of 8610
4 cells and
fixed after 6 and 24 h, respectively.
Quantification of matrix degradation was performed using
ImageJ software. Values were determined by measurement of the
fluorescence intensity of the matrix in a single cell mode. Values of
cells transfected with control siRNA were set at 100%. For
comparability, laser intensity was not changed between measure-
ments. For each value, 3630 cells were evaluated. When
indicated, differences between mean values were analyzed using
the Student’s t test. P,0.05 was considered as statistically
significant.
Results
Lasp-1 is a component of the podosomal ring
To analyze a putative podosomal localization of Lasp-1, we
used indirect immunofluorescence and confocal microscopy
(Fig. 1A–E). In transfected human macrophages, Lasp-1 tagged
with the enhanced green fluorescent protein (EGFP-Lasp-1)
colocalized with endogenous vinculin at the ring structure of
podosomes surrounding the actin core (Fig. 1A). Similar results
were obtained with macrophages encoding vinculin-tagged
enhanced yellow fluorescent protein (EYFP) and stained for
endogenous Lasp-1 and F-actin (Fig. 1B). A more detailed analysis
of single podosomes from macrophages using the Volocity
software package confirmed that both endogenous as well as
overexpressed Lasp-1 localize to the podosomal ring structure,
where they partially colocalize with vinculin (Fig. S1A/B).
Whereas macrophages generate podosomes constitutively, in
A7r5 smooth muscle cells, podosome formation can be induced by
stimulation of protein kinase C with the phorbol ester PDBu.
Using this sytem, we observed that in unstimulated A7r5 cells,
Lasp-1 was mainly found at focal adhesions that anchors stress
fibres to the basal membrane (Fig. 1E). Concomitant with the
PDBu-induced cytoskeletal rearrangement, Lasp-1 was enriched at
podosomes in PDBu-treated A7r5 cells, where it colocalized with
the podosome component zyxin (Fig. 1E).
Podosomal localization of Lasp-1 truncation mutants
Lasp-1 is a multidomain protein that can bind different proteins
including F-actin as well as the known podosomal components
zyxin and palladin (Fig. 2A). To determine the specific Lasp-1
domain(s) that mediate(s) its podosomal recruitment, we analyzed
the distribution of various EGFP-tagged Lasp-1 truncation
mutants in transfected macrophages. EGFP fusion proteins
encoding only isolated Lasp-1 domains (SH3, LIM, NEBU)
displayed a diffuse cytosolic distribution indicating that a single
Lasp-1 domain is not sufficient to establish a podosomal
localization (data not shown). In contrast, EGFP-Lasp-1 trunca-
tion mutants that lack either the aminoterminal LIM domain, the
internal NEBU repeats and the adjacent linker region, or the
carboxyterminal SH3 domain all localized to podosomes of
transfected macrophages (Fig. 2B), and also to vinculin-positive
focal adhesions in A7r5 cells (Fig. S2A/B). These data demon-
strate that a combination of at least two distinct functional
domains is involved in the recruitment of Lasp-1 to podosomes.
Lasp-1 is involved in early stages of podosome
biogenesis
Next, live cell imaging experiments with A7r5 cells were
performed to study Lasp-1 dynamics during podosome biogenesis
(Fig. 3). EGFP-Lasp-1 colocalizes with recombinant mRFP-actin
at podosomes of PDBu-treated A7r5 cells (Fig. 3A). Time-lapse
analysis revealed that EGFP-Lasp-1 is recruited to podosomes
during their assembly and remains there until disassembly after 3–
4 minutes (Fig. 3B).
The podosomal component cortactin is known to be crucial for
early steps in podosome biogenesis as the clustering of initiation
factors occurs [13]. When we compared DsRed-cortactin and
EGFP-Lasp-1 in double-transfected, PDBu-treated A7r5 cells,
Lasp-1 Regulates Podosomes
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the rapid assembly process (Fig. 3C).
Lasp-1 knockdown, podosome formation and matrix
degradation
To investigate the functional relevance of Lasp-1 for podosome
formation, we used a siRNA-based approach to knock down Lasp-
1 in PDBu-treated A7r5 smooth muscle cells. Compared to cells
transfected with control siRNA, there was a notable reduction of
the protein level of Lasp-1 in cells transfected with specific siRNA
against Lasp-1 (Fig. S3A/B). Interestingly, podosomes were still
apparent after Lasp-1 knockdown in PDBu-treated cells (Fig. S3B),
indicating that Lasp-1 is not an essential factor for podosome
assembly in A7r5 cells.
Next, we transferred the siRNA approach to human macro-
phages. Transfection of cells with two different siRNAs that target
human Lasp-1 (Oligo A or C) resulted in a marked decrease of
Lasp-1 expression (Fig. S4A). However, immunofluorescence
analysis revealed that similar to the results obtained with
stimulated A7r5 cells, Lasp-1 siRNA transfected macrophages
Figure 1. Lasp-1 is a component of the podosome ring structure. (A, B) Confocal micrographs of primary human macrophages transfected
with constructs encoding (A) EGFP-Lasp-1 and (B) EYFP-Vinculin (green), respectively, and stained with vinculin- or Lasp-1-specific antibodies (with
Alexa488- or Alexa 568-conjugated secondary antibody) for endogenous vinculin or Lasp-1, respectively, and Cy5-conjugated phalloidin for F-actin
(blue). White box indicates detail images below. Bars represent 10 mm. (C, D) 3D reconstruction of single podosomes of primary human
macrophages. Left panels: xyz mode, right panels: xzy mode for the same podosome. (C) Cells were transfected with EGFP-Lasp-1 and stained with
Alexa568-phalloidin for F-actin (podosome core) or vinculin-specific antibody (with Alexa568-labeled secondary antibody) for vinculin (podosome
ring structure; red). (D) Both untransfected cells (stained with Alexa488-phalloidin for F-actin; green) and cells transfected with EYFP-vinculin (green)
were stained with Lasp-1-specific antibody (with Alexa568-labeled secondary antibody) for endogenous Lasp-1 (red). (E) Confocal micrographs of a
rat smooth muscle cell (A7r5), stained with Alexa-594 phalloidin for F-actin (red, upper panel) or zyxin-specific antibody (with Alexa594-labeled
secondary antibody) for endogenous zyxin (red, lower panel) and co-stained with Lasp-1-specific antibody (with Alexa488-labeled secondary
antibody) for endogenous Lasp-1 (green). Lasp-1 and its binding partner zyxin colocalize at F-actin-rich podosomes (merge) in PDBu-treated A7r5
cells. Bars represent 25 mm.
doi:10.1371/journal.pone.0035340.g001
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F-actin and the marker proteins Arp2 and gelsolin (Fig. S4B) as
well as a podosome ring structure that contains vinculin and
paxillin (Fig. S4C). These data suggest that the main structure of
podosomes is not altered in Lasp-1-deficient macrophages.
Next, we measured whether a Lasp-1 knockdown in macro-
phages affects podosome size and number (Fig. 4). Cells that were
treated with specific siRNA against Lasp-1 showed slightly more
podosomes with a larger diameter of the core structure (Fig. 4 D/
E). However, the number of podosomes per cell was decreased
compared to cells treated with control siRNA (Fig. 4 F/G).
Furthermore, overall dynamic of the podosome field per cell was
quantified by measuring the total podosome-covered area per cell
over time (Fig. 4 A–C; Video S1). Macrophages transfected with
Lasp-1-specific siRNA (Oligo A or C) showed a higher variability
of this value, compared to control cells, indicating increased
overall podosome dynamics. By contrast, the size of these cells
showed no difference to controls (Fig. 4 B/C)
To determine the role of Lasp-1 in the dynamics of single
podosomes, we analyzed podosome lifetime, which includes 1)
appearance to dissolution, 2) appearance to fission, and 3) fusion to
dissolution of single podosomes (Fig. 5 A). Importantly, macro-
phages treated with Lasp-1 specific siRNA (Oligo A or C;
Figure 5B) showed a significant decrease (approx. 30%) of mean
podosome lifetime, and especially the number of podosomes
showing short lifetimes (1–3 min) was significantly increased.
(Fig. 5 C/D).
As the degradation of extracellular matrix (ECM) is one of the
main functions of podosomes [33,34], we analyzed the putative
effect of a Lasp-1 knockdown on the matrix degradation capacity.
For this assay, we used macrophages pre-treated with control
siRNA or siRNA targeting Lasp-1 (Oligo A or C), seeded on
coverslips coated with fluorescent-labeled gelatin and analyzed
after 6 hrs of degradation. After this period, a significant reduction
of degradation could be observed in cells treated with siRNA
against Lasp-1 (Fig. 6A). This could also be quantified by
measuring the fluorescence intensity of the degraded area and
resulted in a significant difference compared the degradation level
of control cells (Fig. 6B).
Matrix degradation at podosomes requires the recruitment of
matrix metalloproteinases including MT1-MMP [34]. To test
whether Lasp-1 is involved in this recruitment process, we
analyzed the amount of MT1-MMP-mCherry-containing vesicles
at podosomes from control or Lasp-1 siRNA-treated macrophag-
es. No effect of a Lasp-1 knockdown on the podosomal localization
of MT1-MMP was detected (Fig. S5A/B).
Discussion
Podosomes are highly dynamic (lifetime ca. 2–12 min), actin-
rich structures at the substrate attached site of cells [1,9]. To date,
various cell types are known that form podosomes constitutively
(e.g. osteoclasts, macrophages; [1,2,10,33]) or upon stimulation (e.
g. A7r5 smooth muscle cells; [4,6,29,34,35,36]).
The actin-binding protein Lasp-1 is known to localize at stable
actin-rich structures like focal adhesions and stress fibres, but can
also be found at highly dynamic dorsal membrane ruffles [15,17].
Figure 2. Lasp-1 mutants lacking either the LIM domain, the
NEBU repeats and the Linker region, or the SH3 domain are
still localized at podosomes. (A) Domain structure of Lasp-1
comprising an aminoterminal LIM domain, two nebulin (NEBU) repeats
and an adjacent Linker region mediating actin binding, and a
carboxyterminal SH3 (Src homology 3) domain that binds zyxin and
palladin (N=aminoterminus, C=carboxyterminus). (B) Confocal micro-
graphs of primary human macrophages transfected with EGFP-Lasp-1
deletion constructs (green) and stained with vinculin-specific antibody
(with Alexa568-conjugated secondary antibody) for vinculin (red) and
Cy5- phalloidin for F-actin. Constructs include EGFP-Lasp-1 wildtype
(wt), EGFP-Lasp-1DLIM (lacking the LIM domain), EGFP-Lasp-1DSH3
(lacking the SH3 domain), and EGFP-Lasp-1DN-L (lacking the NEBU
repeats and the Linker region). White boxes indicate detail images
below. Bars represent 10 mm.
doi:10.1371/journal.pone.0035340.g002
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between Lasp-1 and zyxin and palladin, led us to investigate
whether Lasp-1 is a component of podosomes, too.
In the current study, we observed Lasp-1 localization at
podosomes in smooth muscle cells and human macrophages,
respectively (Fig. 1; Fig. S1). Our immunofluorescence analyses
revealed, that Lasp-1 is localized in the ring structure of
podosomes and displays a distribution that is similar to that of
other adhesion plaque proteins such as vinculin, zyxin and paxillin
[1,12,37]. Our data from experiments with Lasp-1 truncation
mutants demonstrated that a proper podosomal localization
requires the combinantion of at least two functional domains of
the protein. Neither the NEBU repeats that are known to associate
with F-actin, nor the SH3 domain that binds to paxillin and zyxin
were sufficient or necessary to target a EGFP fusion protein to
podosomes (Fig. 2). These findings are in line with a recent study
demonstrating, that various truncation mutants of Lasp-1 lacking
different domains are still recruited to focal adhesions [17].
We observed a comparable localization of Lasp-1 and the early
podosome marker cortactin at sites of initial podosome formation
(Fig. 3B). Cortactin is known to be crucial for the initiation of actin
polymerization at pre-podosome structures [5,12,13,38,39]. As
Lasp-1 and cortactin display similar dynamics during podosome
biogenesis, we speculated that Lasp-1 is associated with early
stages of podosome biogenesis, too. To prove this, we used a
siRNA-based approach to knock down Lasp-1 in PDBu-treated
A7r5 cells (Fig. S3). Interestingly, we observed no differences in the
overall number of podosomes in Lasp-1 knockdown A7r5 cells.
However, in human macrophages with a decreased Lasp-1
expression, we observed alterations in several parameters of
podosomes: decreased lifetime, smaller diameter and decreased
podosome numbers per cell. Moreover, also the degradation
capacity of podosomes was diminished in these cells (Fig. 5/6).
These data point to potential cell type-specific differences in the
recruitment or regulation of both structural and functional
podosome components. In this context, it should also be
mentioned that macrophages form podosomes constitutively,
Figure 3. Lasp-1 recruitment is associated with early stages of podosome biogenesis. (A) Colocalization of recombinant EGFP-Lasp-1 and
recombinant mRFP-actin at podosomes in PDBu-treated A7r5 cells. The white box marks the enlargement shown in Fig. 3B. Bar represents 25 mm. (B)
Appearance of EGFP-Lasp-1 during assembly and disassembly of podosomes (white boxes) in PDBu-treated cells over a period of 4 min. Inserts in the
pictures taken at 0 s, 2 min. and 4 min. show the merged EGFP-Lasp-1 (green) and mRFP-actin (red) signals in two individual podosomes. Bar
represents 2 mm. (C) Colocalization of EGFP-Lasp-1 (upper row) and DsRed-cortactin (middle row, merged pictures in the lower row) during initial
stages of podosome assembly in PDBu-treated A7r5 cells over a period of 2 min. An individual podosome is marked by a red circle. Bars represent
25 mm (left panel) or 2 mm (right panels), respectively.
doi:10.1371/journal.pone.0035340.g003
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induced by stimulating PKC, and thus not directly comparable. In
a similar scenario, knockdown of cortactin in carcinoma cells
resulted in decreased matrix degradation ability of the podosome-
related invadopodia [40]. In these cells, secretion of the matrix
metalloproteinases (MMP) MMP-2 and MMP-9 as well as cell
surface exposure of the transmembrane isoform MT1-MMP was
found to closely correlate with cortactin expression levels.
Although we did not detect a direct correlation between Lasp-1
expression and the recruitment of MT1-MMP-containing vesicles
to podosomes, our results are consistent with the idea that Lasp-1
may be important for the local release of lytic enzymes at matrix
degrading podosomes in macrophages.
In summary, our study shows that Lasp-1 is a novel component
of the podosomal ring structure. Although Lasp-1 is recruited to
podosomes at early stages of their assembly, the protein is probably
not necessary for the initiation of podosome formation. However,
Lasp-1 is involved in of the regulation of several podosome
Figure 4. Impact of a siRNA-mediated knockdown of Lasp-1 on podosome numbers and structure in macrophages. Primary human
macrophages were treated with control siRNA or Lasp-1 specific siRNA (Oligo A or C). (A–C) Podosome-covered area was analyzed by life cell
imaging, with example shown in (A). Pictures were taken every 30 sec. over 30 min. (n=364 cells). Average area per cell was set at 100%. Values were
plotted as box graphs, with whiskers from 1–99% (B). Note higher variability of podosome-covered areas in cells treated with Lasp-1-specific siRNA.
(C) Measured cell size from cells used in (B). (means+SD; ns=not significant). (D–G) Diameter of the podosome cores (D, E) and number of
podosomes per cell (F, G) were evaluated from cells treated with Lasp-1-specific siRNA (Oligo A (D, F; purple); Oligo C (E,G; brown)) or control siRNA
(grey). Insets (d, e) show details taken from graph (means 6SE, n=368 (D, E); means6SE n=3656 (F, G)).
doi:10.1371/journal.pone.0035340.g004
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35340Figure 5. Podosome lifetime is altered in Lasp-1 knockdown macrophages. Primary human macrophages were treated with Lasp-1-specific
siRNA (Oligo A or C) or control siRNA. (A) Examples for podosome dynamics included in the analysis. Shown are single podosomes of cells co-
transfected with siRNA and Lifeact-TagGFP2. Podosome lifetime is defined as 1) appearance to dissolution, 2) appearance to fission, or 3) fusion to
dissolution. (B–D) Measurement of podosome lifetime from cells treated with Lasp-1-specific siRNA, compared to controls. Double asterisks indicate
values highly significant different from controls with P,0.004 (means+SD, n=364) (B). (C, D) Graph showing detailed podosome lifetime analysis,
data from (B), of cells transfected with Lasp-1-specific siRNA (Oligo A (C; purple); Oligo C (D; brown), compared to controls (C, D; grey; (means+SE;
n=3 64;)).
doi:10.1371/journal.pone.0035340.g005
Figure 6. Knockdown of Lasp-1 impairs the matrix degradation capacity of podosomes from human macrophages. A) Confocal
micrographs of macrophages transfected with control siRNA or siRNAs (Oligo A or C) specific for human Lasp-1, and seeded on rhodamine-labeled
gelatin (red). Cells were fixed after 6 h and stained with Cy5-phalloidin for F-actin (blue). Matrix degradation is visible as dark areas by concomitant
loss of the fluorescent label. White bars represent 10 mm. (B) Statistical quantification of matrix degradation in cells treated with control siRNA or
siRNAs specific for Lasp-1. Measurement of the fluorescence intensity of the degraded area was used to evaluate the degree of degradation.
Complete absence of signal was set as 100% degradation and the evaluated cells were scored into groups depending on the degree of matrix
degradation (0%–25%; 26%–100%). Single asterisks indicate values significantly different from control with a P value,0.05 (means with n=3630).
doi:10.1371/journal.pone.0035340.g006
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35340parameters including size, number and lifetime and also regulates
the matrix degradation capacity of podosomes. These activities
reveal Lasp-1 as a novel important regulator of podosomes and
also point to Lasp-1 as a potential target for the modulation of
invasive cell migration.
Supporting Information
Figure S1 Lasp-1 is a component of the podosome ring
structure. 3D reconstruction of single podosomes of primary
human macrophages. Fluorescence micrographs (shown and
described in Figure 1 C, D) were converted in silico into an
isosurface mode using Volocity 3D Image Analysis Software. Left
panels: xyz mode, right panels: xzy mode for the same podosome.
It is important to note that common localization of proteins to
either core or ring structures of podosomes does not necessarily
imply exact colocalization, as apparently subdomains exist within
both structures. Thus, both vinculin and Lasp-1 clearly localize to
the podosome ring, but they only overlap partially.
(TIF)
Figure S2 Recruitment of Lasp-1 truncation mutants to
focal adhesions. (A) A7r5 cells were transfected with constructs
encoding EGFP-tagged Lasp-1 wildtype (wt) or various truncation
mutants that lack individual domains. Fixed cells were stained for
the focal adhesion marker protein vinculin using specific primary
antibody (with Alexa594-labeled secondary antibody) (red). Scale
bars represent 5 mM. (B) Lack of localization of individual Lasp-1
domains at vinculin-positive focal adhesions. A7r5 cells were
transfected with constructs encoding EGFP-tagged Lasp-1 do-
mains. Fixed cells were stained for the focal adhesion marker
protein vinculin using specific primary antibody (with Alexa594-
labeled secondary antibody) (red). Scale bars represent 5 mM.
(TIF)
Figure S3 SiRNA-mediated Lasp-1 knockdown does not
prevent podosome formation in PDBu-treated A7r5
cells. (A) Western blot analysis of Lasp-1 and ß-tubulin expression
in A7r5 cells transfected with control siRNA (lane 1) or siRNA
targeting Lasp-1 mRNA (Oligo A, lane 2) for 72 h. (B) A7r5 cells,
transfected with Lasp-1 specific siRNA (Oligo A) or control
siRNA, respectively and treated with PDBu, were fixed and
stained with Lasp-1-specific antibody (and Alexa488-conjugated
secondary antibody) for endogenous Lasp-1 and Alexa 594-
phalloidin for F-actin. Treatment of A7r5 cells with Lasp-1 siRNA
(right column) decreases the detectable Lasp-1 protein level, but
does not prevent PDBu-induced formation of F-actin-rich
podosomes. Bar represents 25 mM.
(TIF)
Figure S4 Knockdown of Lasp-1 in human macrophages
does not affect the overall structure of podosomes. (A)
Western Blot analysis of Lasp-1 and ß-actin expression in human
macrophages transfected twice with control siRNA (lanes 1 and 3)
or two different oligonucleotides (lanes 2 (Oligo A) and 4 (Oligo C))
targeting Lasp-1 mRNA. (B,C) Confocal micrographs of primary
human macrophages treated with control siRNA or Lasp-1-
specific siRNA (Oligo A or C). Cells were fixed and stained with
Alexa568-phalloidin for F-actin (highlighting podosome cores; red)
and with Arp2- or gelsolin-specific antibodies (with Alexa488-
conjugated secondary antibody) for Arp2 or gelsolin (podosome
cores; green) or with vinculin- or paxillin-specific antibodies (with
Alexa488-conjugated secondary antibody) for vinculin and paxillin
(podosome ring structure; green), respectively. White bars indicate
10 mm.
(TIF)
Figure S5 Lasp-1 expression does not correlate with a
recruitment of MT1-MMP to podosomes in macrophag-
es. (A) Confocal micrograph of a macrophage transfected with
MT1-MMP-mCherry (red), fixed and stained with Alexa488-
phalloidin to stain F-actin (highlighting podosome cores; green).
Inset shows detail image indicated by white box, with examples of
a MT1-MMP-mCherry containing vesicle contacting a podosome
(arrow) and a vesicle adjacent to, but not contacting a podosome
(arrowhead). Bar indicates 10 mm. (B) Primary human macro-
phages were treated with Lasp-1-specific siRNA (Oligo A or C) or
unspecific control siRNA and cotransfected with MT1-MMP-
mCherry. Cells were fixed and stained with Alexa488-phalloidin.
Percentages of podosomes per cell in contact with MT1-MMP-
mCherry containing vesicles were.evaluated by measuring the
fluorescence intensity. Values are means (+SE; n=364; n.s.=not
significant).
(TIFF)
Video S1 Knockdown of Lasp-1 mediates higher vari-
ability of the area of podosomes in macrophages.
Confocal time lapse series of primary human macrophages pre-
treated with control and Lasp-1-specific siRNA (Oligo A or C),
respectively, expressing Lifeact-TagGFP2 (green) highlighting F-
actin (exposure time at 488 nm: 359 ms, acquisition rate: 1
image/30 sec; frame rate: 10 f/s; sequence: 30 min). Note higher
variability of the area of podosomes of cells treated with Lasp-1
specific siRNA compared to control cell.
(MOV)
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